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Matrix proteinSendai virus (SeV) M protein has a YLDL motif, which is essential for budding of virus-like particles (VLPs) by
expression of the M protein. We investigated the importance of the YLDL motif for SeV budding. Virus
budding of an M-deﬁcient SeV was not rescued by transient expression of motif mutants, M-A2 (ALDA) and
M-A4 (AAAA), and viruses possessing those mutations hardly propagated in cultured cells. However, a
budding-competent revertant virus, SeV M-A2R, was obtained from SeV M-A2, and nucleotide sequencing
showed an ALDV sequence at the motif instead of the ALDA sequence derived fromM-A2. The M-A2R protein
rescued budding of an M-deﬁcient SeV, formed VLPs when expressed with viral C protein, and restored the
capacity to bind with Alix/AIP1. The results indicate that the YLDL motif is essential for efﬁcient budding in
the context of virus infection and suggest involvement of Alix/AIP1 in SeV budding.nteracting protein X/1; ESCRT,
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Enveloped virus budding requires host function. Investigation of
retroviruses, rhabdoviruses, ﬁloviruses and other enveloped viruses
has revealed that the matrix (or Gag) protein has a driving force for
virus budding, and the late (L) domain, which is essential for the late
stage of virus maturation, has been identiﬁed in the matrix protein. In
the case of human immunodeﬁciency virus (HIV)-1, the p6 protein in
the Gag polyprotein has a PTAP motif, which interacts with the host
factor Tsg101. The p9 protein in the Gag protein of equine infectious
anemia virus (EIAV) has a YPDL motif, which interacts with the host
factor Alix/AIP. In the case of Rous sarcoma virus, the Gag protein
interacts with an Nedd4-like ubiquitin ligase through its PPPY motif.
Interactions of the viral matrix protein with particular host factors
through these L domains, the consensus sequences of which are P(S/
T)AP, YPxnL, and PPxY (x indicating any amino acid residue and xn
indicating any sequence), are thought to recruit host vacuolar sorting
machinery, the endosomal sorting complex required for transport
(ESCRT), to budding sites and facilitate virus budding, especially by
facilitating membrane pinch-off at the late step of virus budding
(reviewed in Bieniasz, 2006; Demirov and Freed, 2004; Freed, 2002;
Pornillos et al., 2002). In other viruses such as paramyxoviruses,however, these typical L domains are not found in thematrix proteins,
and the presence of such motifs and involvement of the vacuolar
protein sorting machinery in virus budding remain to be investigated
(Chen and Lamb, 2008; Harrison et al., 2010; Schmitt and Lamb,
2004).
Sendai virus (SeV), a prototype of Paramyxoviridae, causes
respiratory diseases in rodents such as mice and rats. The single-
stranded negative-sense genomic RNA of SeV directs synthesis of six
major structural proteins, N, P, M, F, HN and L, and additional
accessory proteins, C and V. The matrix (M) protein lies beneath the
lipid envelope and interacts with the inner leaﬂet of the lipid bilayer
of the plasmamembrane, the cytoplasmic tails of viral glycoproteins, F
and HN, and the viral nucleocapsid (Parks and Lamb, 2007).
Expression of the M protein alone in the absence of other viral
proteins causes release of M protein-containing vesicles (virus-like
particles: VLPs) from cells (Sugahara et al., 2004; Takimoto et al.,
2001). Hence, the M protein is thought to be a major driving force for
virus budding. We have shown that the amino acid motif, YLDL, of SeV
M protein located at positions 49–52 is important for efﬁcient
production of VLPs and for interaction of the M protein with Alix/
AIP1 (Irie et al., 2007). Mutant M proteins, M-A2 and M-A4,
possessing ALDA and AAAA motifs (underlines denoting mutated
residues), respectively, instead of the YLDL motif abrogated VLP
formation and binding capacity with Alix/AIP1 (Irie et al., 2007).
In the present study, we investigated the importance of the YLDL
motif in the context of virus infection. We rescued the release of M-
deﬁcient virus by supplying the wild-type or mutant M protein in
trans. We also recovered mutant viruses possessing M-A2 or M-A4
mutation. The recovered viruses appeared to lack budding ability and
spread to neighboring cells with limited efﬁciency. Furthermore, a
Fig. 1. Rescue of SeV-ΔM budding by transient expression of M-mutant proteins.
(A) Schematic view of SeV-ΔM (SeV18+/ΔM-GFP). (B–E) 293T cells were transfected
with M protein expression plasmids and subsequently infected with SeV-ΔM at an input
m.o.i. of 5 at 24 h post-transfection. At 24 h after infection, the culture medium and cell
lysates were harvested separately. (B) Detection of theM protein in the cells at 24 h post-
transfection by Western blotting. (C) Fluorescent imaging of the cells infected with SeV-
ΔM at 24 h post-infection. (D) The culture mediumwas treated with trypsin and used for
inoculation to fresh LLC-MK2 cells, and the cells were observed by light and ﬂuorescent
microscopy. (E) Infectivity in the culture medium was measured after trypsin treatment.
Results of three independent experiments are shown, and error bars show standard
deviation.
335T. Irie et al. / Virology 405 (2010) 334–341growth-competent revertant virus with a mutation at the motif was
obtained. The results indicate the importance of the YLDL motif in the
M protein for efﬁcient virus budding.
Results
Rescue of M-deﬁcient virus by transiently expressed M protein
To investigate the role of the YLDL motif of the M protein in virus
budding, we tried to rescue budding of an M-deﬁcient virus by
transient expression of mutant M proteins. 293T cells were trans-
fected with M-expressing plasmids, pCAG-M-WT, pCAG-M-A2 and
pCAG-M-A4, and further infected with SeV18+/ΔM-GFP (SeV-ΔM),
whose M gene is replaced with the GFP gene (Fig. 1A). M protein
expression in the transfected cells was conﬁrmed byWestern blotting
and SeV-ΔM infection was detected by observation of green
ﬂuorescence (Figs. 1B, C). The culture medium was collected 24 h
after virus infection, treated with trypsin, and used for inoculation to
fresh LLC-MK2 cells. Green ﬂuorescence was detected when cells were
transfected with pCAG-M-WT but not with pCAG-M-A2 or pCAG-M-
A4 (Fig. 1D). Infectivity in the culture medium was ca. 1×106 cell-
infecting units (CIU)/ml in pCAG-M-WT transfection and ca.
1×103 CIU/ml in pCAG-M-A2 or pCAG-M-A4 transfection, equivalent
to the infectivity in empty vector transfection (Fig. 1E). SeV-ΔM has
been shown to abolish virus budding almost completely (Inoue et al.,
2003). Thus, the presence of viral infectivity in the supernatant
strongly suggests that the supplied wild-type M protein supported
budding of SeV-ΔMand that theM-A2 andM-A4mutations abrogated
the supporting capacity, underscoring the importance of the YLDL
sequence of the M protein in virus propagation.
We next investigated whether expression of M-A2 or M-A4 has an
effect on SeV budding. M proteins were transiently expressed in 293T
cells and the cells were subsequently infected with the wild-type SeV.
There was no substantial difference in the amounts of infectious virus
released into the medium (data not shown), indicating that neither
M-A2 nor M-A4 showed a dominant negative phenotype to SeV
budding.
Recovery of viruses possessing M-A2 and M-A4 mutations
SeV genomic cDNAs possessing M-A2 and M-A4 mutations were
constructed and used for virus recovery as described in Materials and
methods. Viral infectivity was detected in the M-A2 and M-A4 cell
lysates (ca. 102–103 CIU/ml, results from two independent experi-
ments). Conﬂuent monolayers of LLC-MK2 cells were infected with
the viruses and maintained in the medium containing trypsin. At 24 h
and 48 h post-infection, virus-infected cells appeared to have spread
to only neighboring cells in the case of SeV M-A2 and SeV M-A4,
accompanying small cell fusion (Fig. 2). On the other hand, SeV-ΔM,
infected at a similar m.o.i., occasionally demonstrated larger cell
fusion (Fig. 2), as described previously (Inoue et al., 2003). On the
other hand, SeV M-WT infection efﬁciently spread and almost all of
the cells appeared to be infected after 48 h without cell fusion (Fig. 2).
Virus spreading thus appears to be severely limited in SeV M-A2 and
SeV M-A4, and this may be for the most part due to limited virus
budding into the medium. Serial passages of the infected cells were
performed to expand infection in the cultured cells. However, the
infected cells did not increase signiﬁcantly even after 20 generations
of serial passages (data not shown).
Inoculation of the initial cell lysates into allantoic cavities of
embryonated chicken eggs resulted in undetectable levels of virus
(less than 2 HA) in the case of SeV M-A2 and SeV M-A4, while 512 HA
of virus was detected in the case of control SeV-WT. This result
suggests that viral spread of SeV M-A2 and SeV M-A4 is also impaired
in embryonated chicken eggs.Egg growth-competent revertant virus from SeV M-A2
Three undiluted passages of the SeV M-A2 stock virus yielded a
high level of HA (512 HA) in one egg, and the obtained virus was
designated SeV M-A2R. The mutant virus showed growth comparable
to that of the wild-type virus in a one-step growth experiment using
LLC-MK2 cells (Fig. 3A). SDS-PAGE of the virus particles collected by
ultracentrifugation through a 20% sucrose layer demonstrated that
SeV M-A2R virion release was comparable to that of SeV M-WT
Fig. 2. Spread of SeV M mutants in cultured cells. Conﬂuent LLC-MK2 cells were infected with SeV at an input m.o.i. of ca. 0.001 and maintained in a medium containing 10 μg/ml
trypsin. After 24 h and 48 h, infected cells were ﬁxed and immunoﬂuorescent staining was performed with anti-SeV anti-serum. Light microscopy images of the cells at 48 h post-
infection are also shown.
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of that of SeV M-WT (Fig. 3C). Virus spread was also observed in LLC-
MK2 cells infectedwith SeVM-A2R at a lowm.o.i. (Fig. 2). Almost all of
the cells were infected after 2 days of infection, indicating efﬁcient
virus spread similar to the wild-type virus (Fig. 2).
Nucleotide sequence analysis revealed that the isolated virus has a
mutation of G to U at position 3825 in the genome, directing the
change of encoded amino acid Ala to Val at position 52 in the M
protein. This amino acid substitution renders themotif 49-ALDA-52 in
M-A2, which had been artiﬁcially mutated from the wild-type 49-
YLDL-52 motif, to a 49-ALDV-52 motif (underlines denoting changed
amino acids from the wild-type motif). The entire genome spanning
the N, P, M, F, HN and L genes of SeV M-A2R (except the leader and
trailer sequences) was sequenced and no additional mutation as
compared with SeV M-A2 was found.
Characterization of the M-A2R protein
M-VLP formation by the expression of M-A2R protein
The M-A2R protein was expressed in 293T cells, and VLPs released
into the culture medium were collected by ultracentrifugation and
analyzed by Western blotting (Fig. 4). While M-WT produced
abundant M-VLPs, M-A2R did not produce M-VLPs efﬁciently
(Figs. 4A, C). The mutation of M-A2R was not sufﬁcient to support
self-budding activity of the M protein, although it supported efﬁcient
virus budding in the context of virus infection. Simultaneous
expression of C, F and HN proteins has been reported to efﬁciently
generate “authentic” VLPs having characteristics close to those of the
virus (Sugahara et al., 2004). Among these proteins, co-expression of
C protein resulted in efﬁcient VLP release, while co-expression of F
and HN proteins did not (Figs. 4A–C).
Simultaneous expression of M-WT and C protein increased the M-
VLP release by ca. 2.5 fold (Figs. 4D–F), consistent with previously
reported results (Irie et al., 2007; Sugahara et al., 2004). Simultaneous
expression of M-A2R and C protein enhanced the M-VLP release, and
the M-A2R protein was detected in the VLP fraction (Figs. 4D–F). On
the other hand, release of the M-A2 protein, which was derived from
budding-incompetent SeVM-A2, was also enhanced by co-expression
of C protein, but to a lesser extent (Figs. 4D–F).
Rescue of M-deﬁcient virus by M-A2R
We next tried to rescue budding of an M-deﬁcient virus by
transient expression of the M-A2R protein. 293T cells were trans-
fected with anM-expressing plasmid, andM protein expression in thetransfected cells was conﬁrmed by Western blotting (Fig. 5A). After
24 h, the cells were further infected with SeV-ΔM. At 24 h after virus
infection, SeV-ΔM infection was detected by observation of green
ﬂuorescence and by Western blotting for the GFP protein and the M
protein (Fig. 5B). The culture mediumwas then collected and used for
inoculation to fresh LLC-MK2 cells following trypsin treatment. Green
ﬂuorescence was detected when cells were transfectedwith pCAG-M-
A2R and pCAG-M-WT but not with pCAG-M-A2 (Fig. 5C). Infectivity in
the culture medium was around 1×106 CIU/ml in pCAG-M-A2R and
pCAG-M-WT transfection and ca. 1×102 CIU/ml in pCAG-M-A2
transfection, equivalent to the infectivity in empty vector transfection
(Fig. 5D). The results suggest that the M-A2R protein supplied in trans
supported budding of SeV-ΔM.Interaction of M-A2R with Alix
We also tested the interaction of M-A2R and a host factor, Alix/
AIP1. A mammalian two-hybrid system revealed that the M-A2R
protein restored interaction with Alix/AIP1 to a level similar to that of
M-WT (Figs. 6A, B). Immunoprecipitation of the cell lysates with anti-
SeV M protein and Western blotting using anti-HA antibody revealed
the presence of HA-tagged Alix protein in M-WT and M-A2R protein
expression but not in M-A2 expression (Fig. 6C). IP-Western blotting
with the use of the two antibodies in the reverse order also showed
similar results. These results indicate restoration of binding of M-A2R
with Alix.Stability of the M-A2R protein
The M proteins were expressed in 293T cells, and at 24 h post-
transfection, proteins were pulse-labeled with [35S]cysteine and
[35S]methionine for 10 min and chased in DMEM for the indicated
periods. The M proteins were immunoprecipitated and analyzed by
SDS-PAGE (Fig. 7A), and protein bands were quantitated. The
amounts of M protein at 0-min chase were set to 100% and the
ratios of those at 30-min and 60-min chase were plotted in a graph
(Fig. 7B). M-A2 and M-A4 were reduced to ca. 50% in 30-min chase,
and M-A2R, a single point mutant of M-A2, was reduced to a similar
level (ca. 60%) in 30-min chase (Fig. 7B). However, M-WT was
highly stable and increased in 30-min and 60-min chase, probably
due to acquisition of full antigenicity. These results indicate that the
YLDL motif contributes to the stability of the M protein and that
there is no signiﬁcant difference between the stability of M-A2 and
that of M-A2R.
Fig. 3. Replication of SeV M-A2R in cultured cells. (A) LLC-MK2 cells were infected with
SeV at an input m.o.i. of 10 and a part of the culture medium was collected at 6-
h intervals. Infectivity in the culture medium after trypsin treatment was measured and
plotted in the graph. Results of the three independent experiments are shown, and
error bars show standard deviation. (B) LLC-MK2 cells in a 10 cm dish were infected
with SeV at an input m.o.i. of 10. After 24 h, culture medium was collected, clariﬁed by
low-speed centrifugation, and processed for ultracentrifugation through a 20% sucrose
cushion. The virus pellet was solubilized in protein lysis buffer, analyzed by SDS-PAGE,
and visualized by a protein ﬂuorescent dye, SYPRO red, and an FLG-3000G imaging
analyzer (Virions). The cells were processed for Western blotting to detect the N
protein (Cells). (C) Relative ratios of the N protein in the virion (vN) to the N protein in
the cells (cN) are shown in the graph. Results of three independent experiments are
shown, and error bars show standard deviation.
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We previously showed that the 49-YLDL-52 motif of the SeV M
protein was essential for M-VLP budding when the M protein alone
was expressed in cultured cells and that the introduction of mutations
to the motif (M-A2: ALDA, M-A4: AAAA, underlines indicating
mutated residues from the original YLDL motif) abrogated M-VLP
budding as well as binding with the host factor, Alix/AIP1 (Irie et al.,
2007). In the present study, we investigated the contribution of the
YLDL motif to SeV budding in the context of virus infection. Firstly,
budding of SeV lacking the M protein (SeV-ΔM) was complemented
by the trans supplied M protein. The wild-type M protein restored
virus budding, while the M-A2 and M-A4 proteins failed to do so.
Secondly, the mutant virus possessing M-A2 or M-A4 mutation in thegenome appeared to spread only by cell-to-cell transmission in
cultured cells. In the process, a revertant virus that was able to grow
efﬁciently in embryonated chicken eggs was obtained from SeVM-A2.
The revertant virus, SeVM-A2R, propagated well in cultured cells, and
its budding efﬁciency was comparable with that of SeV M-WT. The M
protein of SeV M-A2R had a valine substitution at position 52 (49-
ALDV-52), instead of an alanine for M-A2 (49-ALDA-52). Budding of
the M-deﬁcient SeV was rescued by trans supplied M-A2R protein,
and the M-A2R protein was capable of interacting with Alix/AIP1.
These results demonstrate the importance of the YLDL motif in SeV
budding and suggest involvement of the interaction of the M protein
with Alix/AIP1 in SeV budding.
The mutations at the YLDL motif were found to destabilize the M
proteins; in a pulse-chase labeling experiment, M-A2 and M-A4 were
reduced to ca. 50% in 30-min chase and the revertant protein, M-A2R,
was reduced to ca. 60% in 30-min chase, while M-WT was highly
stable (Fig. 7). On the other hand, no signiﬁcant difference was
detected in protein stability between M-2A and M-2AR, and this does
not seem to cause a drastic difference in support of SeV budding.
The M-A2R protein expressed alone did not result in efﬁcient M-
VLP release from cells (Fig. 4). In parainﬂuenza virus 5 (PIV5) and
mumps virus, expression of the M protein alone does not produce M-
VLPs efﬁciently, but co-expression of other viral proteins such as the
nucleocapsid protein and the viral glycoprotein facilitates M-VLP
budding (Li et al., 2009; Schmitt et al., 2002). Thus, we expressed
other SeV proteins in addition to the M-A2R protein and found that
the C protein enhanced M-VLP release. On the other hand, the release
of VLPs by M-A2, which was derived from budding-incompetent SeV
M-A2, was also facilitated by co-expression of C protein (Fig. 4; Irie et
al., 2007), although the extent of M-A2+C budding was less than that
of M-A2R+C budding (Fig. 4). Self-budding ability by M protein
expression does not appear to be related to virus-budding-supporting
activity in this case. The mechanism by which the M-A2R protein
supports SeV budding remains to be elucidated. Since these two
proteins, M-2A and M-2AR, are different in their binding with Alix
(Fig. 6), Alix may be involved in this process.
The matrix and Gag proteins of retroviruses, rhabdoviruses,
ﬁloviruses and other viruses have a short amino acid motif, L domain,
which is important for virus budding. The motifs consisting of P(S/T)
AP, YPxnL and PPxY interact with host factors, Tsg101, Alix/AIP1 and
Nedd4-like ubiquitin ligase, respectively, recruiting ESCRT to the
budding site. The L domains of differentmotifs are replaceable by each
other in many cases (reviewed in Bieniasz, 2006; Demirov and Freed,
2004; Fujii et al., 2007; Pornillos et al., 2002). The YLDLmotif of SeVM
protein is similar to the L domain in facilitation of virus budding and
interaction with Alix/AIP1. However, the motif does not ﬁt with the
consensus L domain sequence and is not interchangeable with the L
domains (Irie et al., 2007). L domain candidates of other paramyx-
oviruses identiﬁed so far are YMYL or YPLGVG for Nipah virus
(Ciancanelli and Basler, 2006; Patch et al., 2008), FPIV for parain-
ﬂuenza virus type 5 (Schmitt et al., 2002), and FPVI for mumps virus
(Li et al., 2009). These motifs do not exactly ﬁt with consensus L
domain sequences, and their interacting host proteins are unknown.
These results suggest that the paramyxovirus budding machinery is
distinct from that of L domain-possessing viruses.
In SeV, not only the M protein but also an accessory protein, the C
protein, interacts with Alix/AIP1 (Sakaguchi et al., 2005). The
interaction recruits Alix/AIP1 to the budding site and enhances M-
VLP budding (Irie et al., 2007; Sugahara et al., 2004). The C protein
interacts with Alix/AIP1 at the 212–357 residues in the Bro-like
domain, whereas the M protein interacts with Alix/AIP1 at residues,
1–211 (Irie et al., 2007). SeV M-VLP budding was inhibited by Alix/
AIP1 siRNA and by over-expression of the Alix fragment 424–628
corresponding to the V domain of Alix/AIP1 (Irie et al., 2007). These
ﬁndings together with the results of the present study suggest that
Alix/AIP1 has an essential role in the budding of M-VLP and SeV. The
Fig. 4. (A–C) Efﬁciency of M-VLP budding. 293T cells were transfected with an M expression plasmid with or without pCAG-C, pCAG-F or pCAG-HN. After 24 h, VLPs in the medium
were concentrated by ultracentrifugation through a 20% sucrose cushion. VLPs (A) and cell lysates (B) were analyzed by SDS-PAGE and Western blotting using anti-SeV serum and
anti-C serum. (D–F) 293T cells were transfected with an M expression plasmid with or without pCAG-C. After 24 h, VLPs in the medium were concentrated by ultracentrifugation
through a 20% sucrose cushion. Cell lysates (D) and VLPs (E) were analyzed by SDS-PAGE andWestern blotting using anti-SeV serum and anti-C serum. (C, F) M protein release rate
was calculated and plotted in a graph. Results of three independent experiments are shown, and error bars show standard deviation.
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known. There is another example indicating that the N protein and
the V protein of human parainﬂuenza virus 2 interact with Alix/AIP1
independently (Nishio et al., 2007). On the other hand, Gosselin-
Grenet et al. (Gosselin-Grenet et al., 2007) knocked down Alix/AIP1
expression by siRNA technology and reduced intracellular Alix/AIP1
to 1%–15%, followed by infection with SeV, and they concluded that
Alix/AIP1 is not required for SeV budding in the context of virus
infection. The reason for this contradiction with the present work is
unknown.
Alix/AIP1 is a component of ESCRT, which binds with the CHMP4
protein. In EIAV budding, recruitment of the ESCRT machinery to the
budding site by interaction of the Gag p9 protein with Alix/AIP1 is
thought to drive virus budding (Martin-Serrano et al., 2003; Strack et
al., 2003). The binding of Alix/AIP1 with SeV proteins may indicate
involvement of ESCRT in SeV budding. EIAV p9 protein binds Alix/
AIP1 in the region around phenylalanine at position 676 in the V
domain (Fisher et al., 2007; Lee et al., 2007), and the binding region is
different from the binding regions of SeV M and C, as mentioned
above. It is thus possible that Alix/AIP1 is involved in SeV budding
independently of the ESCRT machinery, since Alix/AIP1 is multifunc-
tional in membrane trafﬁc (Falguieres et al., 2009; Odorizzi, 2006).
While Alix/AIP1 is known to play important roles in SeV budding,
speciﬁc mechanisms remain to be elucidated. Further efforts toelucidate the mechanisms will provide a deeper understanding of
virus budding and may contribute to the development of effective
antiviral strategies for blocking the late steps of the enveloped virus
life cycle.
Materials and methods
Cells, viruses and antibodies
Human renal epithelial cell-derived 293T cells, rhesus macaque
kidney-derived LLC-MK2 cells, and BHK-T7 cells, baby hamster
kidney-derived BHK-21 cells expressing T7 RNA polymerase (Nishi-
himura et al., 2007), were propagated in Dulbecco's modiﬁed Eagle's
minimal essential medium (DMEM) supplemented with 10% fetal calf
serum. SeV18+/ΔM-GFP (named SeV-ΔM in this paper), in which the
M gene is replaced with GFP cDNA, has been described in a report by
Inoue et al. (Inoue et al., 2003). The wild-type SeV Z strain derived
from a genomic DNA (Kato et al., 1996) and other mutant SeV strains
were propagated in embryonated chicken eggs at 33 °C for 3 days, and
the allantoic ﬂuids were kept as a stock virus. Infectivity was
measured using an immunoﬂuorescent infectious focus assay (Kiyo-
yotani et al., 1990) and expressed as cell-infecting units (CIU)/ml.
Rabbit anti-sera against puriﬁed SeV particles (Kiyotani et al., 1990),
SeV M protein (Inoue et al., 2003), and green ﬂuorescent protein
Fig. 5. Rescue of SeV-ΔM budding by transient expression of M-A2R protein. 293T cells
were transfected with M protein expression plasmids and subsequently infected with
SeV-ΔM at an input m.o.i. of 5 at 24 h post-transfection. At a further 24 h after infection,
the culture medium and cell lysates were harvested separately. (A) Detection of the M
protein in the cells at 24 h post-transfection by Western blotting. (B) Fluorescent
imaging of the cells infected with SeV-ΔM at 24 h post-infection, and detection of GFP
proteins and M proteins byWestern blotting. (C) The culture medium was treated with
trypsin and used for inoculation to fresh LLC-MK2 cells, and the cells were observed by
ﬂuorescent microscopy. (D) Infectivity in the culture medium was measured after
trypsin treatment.
Fig. 6. Interaction of the M protein and Alix/AIP1. (A, B) Mammalian two-hybrid
system. M proteins were fused with a binding domain (BD) and Alix/AIP1 was fused
with a transcription activation domain (AD). Combinations of a BD plasmid and an AD
plasmid as indicated in the ﬁgure were introduced into 293T cells, and expression of the
fusion proteins was conﬁrmed by Western blotting after 24 h (A). Reporter ﬂuorescent
intensity in the medium was measured and is shown in the graph (B). Results are from
three independent experiments, and error bars indicate standard deviation. (C) IP-
Western blotting. M-WT, M-A2, or M-A2R protein was expressed in 293T cells with HA-
tagged Alix (HA-Alix), and cell lysates were prepared after 24 h. Protein expression was
conﬁrmed by Western blotting using anti-HA antibody and anti-SeV M serum. The
lysates were then processed for immunoprecipitation with anti-SeV M serum or anti-
HA antibody, SDS-PAGE, and Western blotting using anti-HA antibody or anti-SeV M
serum, respectively.
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Mouse monoclonal antibody against the HA tag (G036) was
purchased from Applied Biological Materials (Richmond, BC, Canada).
Plasmid preparation
The expression plasmids, pCAG-M-WT (wild type), pCAG-M-A2
and pCAG-M-A4, expressing SeV M and its mutant proteins under the
control of the CAG promoter (Niwa et al., 1991) have been described
by Irie et al. (Irie et al., 2007). pCAG-M-A2R was constructed from the
revertant virus SeV M-A2R by using RT-PCR and by subcloning into
the pCAGGS.MCS vector (provided by Y. Kawaoka). pCAG-C, pCAG-F
and pCAG-HN expressing SeV C, F and HN proteins, respectively, have
been described by Sugahara et al. (2004). Plasmids with M-A2 or M-A4mutations in the full-length genomic cDNA of the SeV Z strainwere
constructed from pSeV(+) (Kato et al., 1996). Plasmids for a
mammalian two-hybrid system were constructed and used as
described by Irie et al. (2007). Nucleotide sequence analysis was
performed by using a 3130x/genetic analyzer (Applied Biosystems)
and SeV genome-speciﬁc primers.
Rescue of budding of M-deﬁcient virus by M protein expression
293T cells in a 6-well plate were transfected with 1 μg of M-
expressing plasmids, pCAG-M, pCAG-M-A2 and pCAG-M-A4, by using
the FuGENE HD transfection reagent (Roche Diagnostics) and were
infected at 24 h post-transfection with SeV-ΔM at an input m.o.i. of 5.
After 24 h, the culture mediumwas collected and used for inoculation
of fresh LLC-MK2 cells after trypsin treatment, and green ﬂuorescence
Fig. 7. Pulse-chase experiments of the M proteins. 293T cells in 6-well plates were
transfected with the indicated plasmid. At 24 h post-transfection, cells were
metabolically labeled with [35S]cysteine and [35S]methionine for 10 min, and the
medium was replaced with DMEM and incubated for various periods. Cells were
solubilized in RIPA buffer and processed for immunoprecipitation using anti-SeV M
serum. After SDS-PAGE, protein bands were visualized and quantitated by using an FLA-
3000G imaging analyzer (A). The amounts of the M protein at 0-min chase were set to
100% and relative amounts were plotted in a graph (B). Results of four independent
experiments are shown, and error bars show standard deviation.
340 T. Irie et al. / Virology 405 (2010) 334–341was observed the next day. Infectivity in the culture medium was
measured, and cell lysates were also collected and processed for
Western blotting to conﬁrm M protein expression.
Western blotting
Western blotting was performed as described previously (Irie et
al., 2007). Brieﬂy, cell lysates were analyzed by sodium dodecyl
sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) and proteins
were transferred onto a PVDF membrane. After blocking, the
membrane was probed with anti-SeV rabbit serum (Kiyotani et al.,
1990) and horseradish peroxidase-conjugated anti-rabbit IgG anti-
body (Santa Cruz Biotechnology). Proteins were further visualized by
using Immobilon Western chemiluminescent HRP substrate (Milli-
pore) and an LAS-1000 plus imaging analyzer (Fuji Biomedicals).
Recovery of SeV from cDNA
Recombinant SeV was recovered from cDNA as described
previously (Kato et al., 1996; Nishimura et al., 2007) with some
modiﬁcations. BHK-T7 cells in a 35 mm dish were transfected with a
plasmid possessing SeV full-length genomic cDNA (2 μg) together
with pGEM-N (0.6 μg), pGEM-P (0.3 μg), and pGEM-L (0.6 μg),
expressing the N, P and L proteins under the T7 promoter,
respectively, and after 24 h, cells were re-seeded into a 10 cm dish.
After the cells had become conﬂuent, themediumwas replaced with a
medium lacking FCS but containing 10 μg/ml trypsin (Merck). After
48 h, cell lysates were harvested and frozen as a stock virus.Immunoﬂuorescent staining
LLC-MK2 cells on a coverslip were infected with the stock virus and
were ﬁxed at 18 h after infection with 0.5% formaldehyde in
phosphate-buffered saline (PBS) at room temperature for 20 min.
The cells were then treated with 100 mM glycine in PBS and 0.1%
Triton X-100 in PBS, stained by using an anti-SeV rabbit serum and an
Alexa Fluor 488-conjugated anti-rabbit IgG antibody (Molecular
Probes), and observed under a ﬂuorescent microscope (TE2000-S,
Nikon).
M-VLP budding assay
VLP budding assay was performed as described by Irie et al. (Irie et
al., 2007) with minor modiﬁcations. Brieﬂy, 293T cells grown in a 6-
well plate were transfected with 1 μg of the indicated plasmids. At
24 h post-transfection, culture mediumwas harvested and clariﬁed at
2000×g for 5 min. The supernatant was then centrifuged at
40,000 rpm (190,000×g) for 2 h through a 20% sucrose cushion in a
Beckman SW55Ti rotor. The pellet was suspended in 50 μl of SDS-
PAGE sample buffer and analyzed by SDS-PAGE (12%), followed by
Western blotting with anti-SeV antibody and anti-C antibody. Cell
lysates were also prepared and analyzed by Western blotting with
appropriate antibodies. Bands of the proteins were quantitated by
Multi Gauge software (Fuji Biomedicals). VLP budding rates are
shown asM protein release rates: the ratio of M protein in VLPs to that
in the total of cell lysates and VLPs.
Immunoprecipitation (IP)-Western blotting
293T cells grown in 6-well plates were transfected with the
indicated plasmids (0.5 μg each), and at 24 h post-transfection, cells
were suspended in cell lysis buffer (0.5% NP-40, 20 mM Tris–HCl, pH
7.4, 150 mMNaCl) containing a “Complete” protease inhibitor cocktail
(Roche Diagnostics). Cell lysate samples were immunoprecipitated
with either anti-SeV M or anti-HA antibody. The immunoprecipitates
obtained with anti-SeV and anti-HA antibodies were separated by
SDS-PAGE, followed byWestern blotting with anti-HA and anti-SeVM
antibodies, respectively. Cell lysates were also directly subjected to
Western blotting to conﬁrm expression of Alix and M proteins.
Mammalian two-hybrid system
Matchmaker Mammalian Assay Kit 2 (Clontech) was used for the
mammalian two-hybrid assay, and experiments were performed
according to the manufacturer's protocol. GAL4 DNA-binding domain
(BD) and VP16 activation domain (AD) plasmids for this assay were
prepared as described by Irie et al. (2007). 293T cells were transfected
with the indicated AD and BD plasmids together with a pG5SEAP
reporter plasmid. At 48 h post-transfection, the culture medium was
harvested and processed for a secreted alkaline phosphatase (SEAP)
ﬂuorescence assay. The ﬂuorescence of each sample was measured
with a plate ﬂuorometer (ARVO-SX, PerkinElmer).
Pulse-chase experiments
Subconﬂuent 293T cells grown in 6-well plates were transfected
with 1 μg of the indicated plasmid. At 24 h post-transfection, cells
were metabolically labeled with [35S]cysteine and [35S]methionine
(2.5 MBq/ml; EXPRESS Protein Labeling mix, [35S], PerkinElmer) for
10 min, and the medium was replaced with DMEM and incubated for
various periods. Cells were solubilized in radioimmunoprecipitation
assay (RIPA) buffer (10 mM Tris–HCl, pH 7.4, 1% Triton X-100, 1%
sodium deoxycholate, 0.1% SDS, and 150 mMNaCl) containing 50 mM
iodoacetamide and 1 mM phenylmethylsulfonyl ﬂuoride and pro-
cessed for immunoprecipitation using anti-SeV M serum. After SDS-
341T. Irie et al. / Virology 405 (2010) 334–341PAGE, protein bands were visualized and quantitated by using an FLA-
3000G imaging analyzer (Fuji Biomedicals).Acknowledgments
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